Quick Answer
Lantern Pharma Inc. reported Stockholders Equity of $6.53 million for fiscal year 2025.
Lantern Pharma Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $6.53M | -69.2% |
| 2024 | $21.19M | -48.2% |
| 2023 | $40.91M | -27.0% |
| 2022 | $56.04M | -21.7% |
| 2021 | $71.57M | +263.3% |
| 2020 | $19.70M | +1988.3% |
| 2019 | $943.3K | +567.4% |
| 2018 | -$201.8K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.59M | -64.0% | -23.4% |
| June 30, 2025 | $12.52M | -59.5% | -25.4% |
| March 31, 2025 | $16.78M | -53.1% | -20.8% |
| December 31, 2024 | $21.19M | -48.2% | -20.3% |
| September 30, 2024 | $26.60M | -41.4% | -14.0% |
| June 30, 2024 | $30.93M | -35.9% | -13.5% |
| March 31, 2024 | $35.77M | -32.0% | -12.6% |
| December 31, 2023 | $40.91M | -27.0% | -9.9% |
- Lantern Pharma Inc. showed a decrease of -69.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, Lantern Pharma Inc.’s stockholders equity has grown by 3338.0% (from -$201.8 thousand to $6.53 million).
- The most recent figure is from Lantern Pharma Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: